Platelet-derived growth factor-d promotes ovarian cancer invasion by regulating matrix metalloproteinases 2 and 9

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 12, 2011, Pages 3367-3370

  Wang, Yuan ^a   Hu, Chaoying ^b   Dong, Ruofan ^a   Huang, Xiaoyan ^a   Qiu, Haifeng ^a,c  

^a Soochow University   (China)

^b Central Laboratory of Shanghai Xuhui Central Hospital   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

D; Derived growth factor; Invasion; Matrix metalloproteinases; Ovarian cancer; Platelet

Indexed keywords

GELATINASE A; GELATINASE B; LYMPHOKINE; MESSENGER RNA; MMP2 PROTEIN, HUMAN; PDGFD PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR;

APOPTOSIS; ARTICLE; CANCER INVASION; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; OVARY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOKINES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; OVARY; PLATELET-DERIVED GROWTH FACTOR; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84864520969     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ahmad A, Wang Z, Kong D, et al (2010). Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-kappaB signaling pathways. Breast Cancer Res Treat, 126, 15-25.
2. Bergsten E, Uutela M, Li X, et al (2001). PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol, 3, 512-6.
3. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
4. Kong D, Banerjee S, Huang W, et al (2008). Mammalian target of rapamycin repression by 3, 3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. Cancer Res, 68, 1927-34.
5. Kong D, Wang Z, Sarkar SH, et al (2008). Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells, 26, 1425-35.
6. Li X, Eriksson U (2003). Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev, 14, 91-8.
7. Liu J, Liao S, Huang Y, et al (2011). PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clin Cancer Res, 17, 3638-48.
8. Reigstad LJ, Varhaug JE, Lillehaug JR (2005). Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBSJ, 272, 5723-41.
9. Schorge JO, Modesitt SC, Coleman RL, et al (2010). SGO White Paper on ovarian cancer: etiology, screening and surveillance. Gynecol Oncol, 119, 7-17.
10. StatBite Ovarian Cancer (2011). Five-Year Stage-Specific Relative Survival Rates (2004-2008). J Natl Cancer Inst, 103, 1287.
11. Ustach CV, Kim HR (2005). Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Mol Cell Biol, 25, 6279-88.
12. Wang Z, Ahmad A, Li Y, et al (2010). Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochim Biophys Acta, 1806, 122-30.
13. Wang Z, Kong D, Banerjee S, et al (2007). Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Cancer Res, 67, 11377-85.
14. Wang Z, Kong D, Li Y, Sarkar FH (2009). PDGF-D signaling: a novel target in cancer therapy. Curr Drug Targets, 10, 38-41.
15. Xu L, Tong R, Cochran DM, Jain RK (2005). Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. Cancer Res, 65, 5711-9.
16. Zhao L, Zhang C, Liao G, Long J (2010). RNAi-mediated inhibition of PDGF-D leads to decreased cell growth, invasion and angiogenesis in the SGC-7901 gastric cancer xenograft model. Cancer Biol Ther, 9, 42-8.